Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-024527
Filing Date
2021-10-28
Accepted
2021-10-28 16:08:28
Documents
1
Period of Report
2021-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3504
  Complete submission text file 0001437749-21-024527.txt   5059
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Issuer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CLEVELAND BIOLABS, INC. 73 HIGH STREET BUFFALO NY 14203
Business Address
SALUCK RANDY S. (Reporting) CIK: 0001576409 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32954 | Film No.: 211358295